Dr. Gordan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 Sneath Ln
San Bruno, CA 94066Phone+1 650-615-6000Fax+1 650-615-6015
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2011 - 2014- University of California (San Francisco)Residency, Internal Medicine, 2009 - 2011
Perelman School of Medicine at the University of PennsylvaniaClass of 2009
Certifications & Licensure
CA State Medical License 2011 - 2026- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 49 citationsCombined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic CholangiocarcinomaXinhua Song, Xianqiong Liu, Haichuan Wang, Jingxiao Wang, Yu Qiao
Clinical Cancer Research. 2019-01-01 - 344 citationsSystemic Therapy for Advanced Hepatocellular Carcinoma: ASCO GuidelineJohn D. Gordan, Erin B. Kennedy, Ghassan K. Abou-Alfa, Muhammad Shaalan Beg, Steven Brower
Journal of Clinical Oncology. 2020-11-16 - 93 citationsRibosomal Stress Couples the Unfolded Protein Response to p53-dependent Cell Cycle Arrest *Fang Zhang, Robert B. Hamanaka, Ekaterina Bobrovnikova-Marjon, John D. Gordan, Mu Shui Dai
The Journal of Biological Chemistry. 2006-10-06
Journal Articles
- Overexpression-Mediated Activation of MET in the Golgi Promotes HER3/ERBB3 PhosphorylationJohn Gordan, MD, Nature
- Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic CholangiocarcinomaJohn D Gordan, Xin Chen, Clinical Cancer Research
Press Mentions
Drug Hobbles Deadly Liver Cancer by Stifling Protein ProductionJanuary 14th, 2019
OncLive® Hosts State of the Science Summit™: Gastrointestinal MalignanciesFebruary 22nd, 2018
John Gordan of UCSF Discusses His Work in Fibrolamellar CarcinomaNovember 13th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
